|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Prepaid expenses | ||||||||||||||
| Other receivables | ||||||||||||||
| Marketable securities | ||||||||||||||
| Accounts receivable | ||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||
| Total current assets | ||||||||||||||
| Investments held in Trust Account | ||||||||||||||
| Deferred offering costs | ||||||||||||||
| Restricted cash | ||||||||||||||
| Property and equipment, net | ||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||
| Other assets | ||||||||||||||
| Total assets | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | ||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||
| Due to related party | ||||||||||||||
| Related Party | ||||||||||||||
| Total due to related party | ||||||||||||||
| Extension note | ||||||||||||||
| Related Party | ||||||||||||||
| Total extension note | ||||||||||||||
| Working capital loan | ||||||||||||||
| Operating lease liabilities, current | ||||||||||||||
| Debt, current portion | ||||||||||||||
| Second lien loans | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Deferred financing obligation | ||||||||||||||
| Debt, net of current portion | ||||||||||||||
| Second lien loans | ||||||||||||||
| Liabilities, redeemable convertible preferred stock and stockholders’ deficit | ||||||||||||||
| Debt, net of current portion | ||||||||||||||
| Deferred underwriting and advisory fees | ||||||||||||||
| Simple agreements for future equity | ||||||||||||||
| Operating lease liabilities, noncurrent | ||||||||||||||
| Common stock warrants | ||||||||||||||
| Other liabilities | ||||||||||||||
| Total liabilities | ||||||||||||||
| Class A ordinary shares subject to possible redemption as of December 31, 2024 | ||||||||||||||
| Redeemable convertible preferred stock | ||||||||||||||
| Series A Cumulative Convertible Preferred Stock | ||||||||||||||
| Cumulative redeemable convertible preferred stock | ||||||||||||||
| Total redeemable convertible preferred stock | ||||||||||||||
| Stockholders’ deficit | ||||||||||||||
| Preference shares, $0.0001 par value; 99,990,000 shares authorized; none issued or outstanding | ||||||||||||||
| Common stock, $0.0001 par value; 1,980,000 shares authorized; 194,1731 and 175,4401 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||
| Common Class A | ||||||||||||||
| Common Class B | ||||||||||||||
| Total common stock, $0.0001 par value; 1,980,000 shares authorized; 194,1731 and 175,4401 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||
| Accumulated deficit | ||||||||||||||
| Total stockholders’ deficit | ||||||||||||||
| Total liabilities, redeemable convertible preferred stock and stockholders’ deficit | ||||||||||||||
| Redemption price (in dollars per share) | ||||||||||||||
| Outstanding shares subject to redemption (in shares) | ||||||||||||||
| Common Class A | ||||||||||||||
| Series A Cumulative Convertible Preferred Stock | ||||||||||||||
| Cumulative redeemable convertible preferred stock | ||||||||||||||
| Total outstanding shares subject to redemption (in shares) | ||||||||||||||
Loading...